Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PASG compared with NEUP: revenue, margins and what each company keeps, and the suppliers and customers both name
PASG
Passage BIO, Inc.
Change
Mkt cap
Revenue
Revenue
NEUP
Neuphoria Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PASG
Passage BIO, Inc.
vs
NEUP
Neuphoria Therapeutics Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PASG, solid
NEUP, dashed
Supply-chain overlap
Revenue flow
PASG: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only PASG
1
—
Gemma
unlisted
supplier
Shared
0
No shared counterparties.
Only NEUP
6
MRK
Merck
customer
—
Danforth Advisors
unlisted
supplier
—
Wolf & Company, P.C
unlisted
supplier
—
WG Partners LLP
unlisted
supplier
2 more · NEUP chain
›
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
PASG
Passage BIO, Inc.
Change
3.44
▼
−2.27%
· post 3.44
Mkt cap
$11.1M
Revenue
$99,000
Q3 FY24
NEUP
Neuphoria Therapeutics Inc.
Change
3.07
▲
+0.33%
· post 3.07
Closed
Oct 30 '26
Mkt cap
$16.5M
Revenue
$15M
Q3 FY25
vs
Compare
Closed
Oct 30 '26
PASG
Passage BIO, Inc.
vs
NEUP
Neuphoria Therapeutics Inc.
3.44
▼
−2.27%
post 3.44
Price
3.07
▲
+0.33%
post 3.07
$11.1M
Mkt cap
$16.5M
Q3 FY24
$99,000
Revenue
$15M
Q3 FY25
Change
Change
PASG
3.44
▼
−2.27%
vs
NEUP
3.07
▲
+0.33%
Closed
Oct 30 '26